131 related articles for article (PubMed ID: 38309306)
1. A microthrombus-driven fixed-point cleaved nanosystem for preventing post-thrombolysis recurrence via inhibiting ferroptosis.
Sun M; Liu C; Liu J; Wen J; Hao T; Chen D; Shen Y
J Control Release; 2024 Mar; 367():587-603. PubMed ID: 38309306
[TBL] [Abstract][Full Text] [Related]
2. Thrombus-targeted nanoparticles for thrombin-triggered thrombolysis and local inflammatory microenvironment regulation.
Zhang H; Qu H; He Q; Gao L; Zhang H; Wang Y; Zhang Z; Hou L
J Control Release; 2021 Nov; 339():195-207. PubMed ID: 34214595
[TBL] [Abstract][Full Text] [Related]
3. Bacteria-propelled microtubular motors for efficient penetration and targeting delivery of thrombolytic agents.
Xie S; Mo C; Cao W; Xie S; Li S; Zhang Z; Li X
Acta Biomater; 2022 Apr; 142():49-59. PubMed ID: 35158079
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy by Regulating the ROS-Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets.
Zhang W; Wang J; Xie Z; Zou H; Chen Q; Xu L; Hu L; Fang N; Xu J; Zhou J; Liu J; Ran H; Wang Z; Zhang Y; Guo D
Small; 2022 Apr; 18(15):e2106252. PubMed ID: 35246943
[TBL] [Abstract][Full Text] [Related]
5. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
Yu W; Yin N; Yang Y; Xuan C; Liu X; Liu W; Zhang Z; Zhang K; Liu J; Shi J
Acta Biomater; 2022 Mar; 140():625-640. PubMed ID: 34902617
[TBL] [Abstract][Full Text] [Related]
6. Urokinase loaded black phosphorus nanosheets for sequential thrombolysis and reactive oxygen species scavenging in ischemic stroke treatment.
Wang D; Zhao Q; Qin J; Guo Y; Zhang C; Li Y
Biomater Sci; 2022 Aug; 10(16):4656-4666. PubMed ID: 35801526
[TBL] [Abstract][Full Text] [Related]
7. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
Collen D; Stassen JM; Verstraete M
J Clin Invest; 1983 Feb; 71(2):368-76. PubMed ID: 6681615
[TBL] [Abstract][Full Text] [Related]
8. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
[TBL] [Abstract][Full Text] [Related]
9. Thrombus-specific/responsive biomimetic nanomedicine for spatiotemporal thrombolysis and alleviation of myocardial ischemia/reperfusion injury.
Guo X; Hong T; Zang J; Shao R; Hou X; Wang K; Liu W; Su F; He B
J Nanobiotechnology; 2022 Dec; 20(1):531. PubMed ID: 36514154
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting fucoidan-based microvesicle for arterial thrombolysis and re-occlusion inhibition.
Chen Z; Yuan C; Ye Y; Lu B; Hu E; Lu F; Yu K; Xie R; Lan G
Carbohydr Polym; 2024 Mar; 328():121703. PubMed ID: 38220339
[TBL] [Abstract][Full Text] [Related]
11. Bacteria-Templated and Dual Enzyme-Powered Microcapsule Motors To Promote Thrombus Penetration and Thrombolytic Efficacy.
Xie S; Li S; Cao W; Mo C; Zhang Z; Huang K; Li X
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37553-37565. PubMed ID: 35948498
[TBL] [Abstract][Full Text] [Related]
12. Engineered platelets-based drug delivery platform for targeted thrombolysis.
Wang S; Wang R; Meng N; Lu L; Wang J; Zhou J; Lu J; Xu Q; Xie C; Zhan C; Li Y; Yu Y; Lu W; Liu M
Acta Pharm Sin B; 2022 Apr; 12(4):2000-2013. PubMed ID: 35847517
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
14. RGD Modified Protein-Polymer Conjugates for pH-Triggered Targeted Thrombolysis.
Li B; Chen R; Zhang Y; Zhao L; Liang H; Yan Y; Tan H; Nan D; Jin H; Huang Y
ACS Appl Bio Mater; 2019 Jan; 2(1):437-446. PubMed ID: 35016307
[TBL] [Abstract][Full Text] [Related]
15. Recombinant lys-plasminogen, but not glu-plasminogen, improves recombinant tissue-type plasminogen activator-induced coronary thrombolysis in dogs.
Mehta JL; Chen L; Nichols WW; Johannesen M; Bregengård C; Hedner U; Saldeen TG
J Am Coll Cardiol; 1995 Mar; 25(3):753-60. PubMed ID: 7860925
[TBL] [Abstract][Full Text] [Related]
16. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
17. Platelet-Mimic uPA Delivery Nanovectors Based on Au Rods for Thrombus Targeting and Treatment.
Yang T; Ding X; Dong L; Hong C; Ye J; Xiao Y; Wang X; Xin H
ACS Biomater Sci Eng; 2018 Dec; 4(12):4219-4224. PubMed ID: 33418820
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for
Li J; Zhang X; Mo Y; Huang T; Rao H; Tan Z; Huang L; Zeng D; Jiang C; Zhong Y; Cai Y; Liang B; Wu J
Front Bioeng Biotechnol; 2022; 10():1038829. PubMed ID: 36324896
[No Abstract] [Full Text] [Related]
19. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors.
Dichek DA; Anderson J; Kelly AB; Hanson SR; Harker LA
Circulation; 1996 Jan; 93(2):301-9. PubMed ID: 8548903
[TBL] [Abstract][Full Text] [Related]
20. Pleiotropic Microenvironment Remodeling Micelles for Cerebral Ischemia-Reperfusion Injury Therapy by Inhibiting Neuronal Ferroptosis and Glial Overactivation.
Li C; Wu Y; Chen Q; Luo Y; Liu P; Zhou Z; Zhao Z; Zhang T; Su B; Sun T; Jiang C
ACS Nano; 2023 Sep; 17(18):18164-18177. PubMed ID: 37703316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
